HSCS HeartSciences Inc.
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

- Industry (SIC)
- FINANCE SERVICES (6199) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 14
- List Date
- 2022-06-15
- CIK
- 0001468492
- Next Earnings
- 2026-12-21
- EPS Forecast
- ($0.62)
- Headquarters
- Southlake, TX
- Homepage
- https://www.heartsciences.com
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|
| Jan | -- | 156.59% | -10.41% | -13.70% | 2.87% | 33.84% |
| Feb | -- | -28.42% | -16.31% | 11.25% | -12.94% | -11.61% |
| Mar | -- | -28.99% | -3.71% | -16.57% | -5.49% | -13.69% |
| Apr | -- | -12.13% | -17.20% | 27.45% | -17.37% | -4.81% |
| May | -- | 18.33% | -40.60% | 1.49% | -16.08% | -9.21% |
| Jun | 10.24% | -9.40% | -8.44% | 1.63% | 23.65% | 3.54% |
| Jul | -17.58% | -1.98% | -23.91% | -20.00% | -25.09% | -17.71% |
| Aug | -7.34% | -22.42% | -12.60% | 11.80% | 47.20% | 3.33% |
| Sep | -20.81% | -39.14% | 50.15% | 1.75% | 33.97% | 5.18% |
| Oct | 100.41% | -42.01% | -38.75% | -14.57% | -14.91% | -1.97% |
| Nov | -54.31% | 5.22% | 1.72% | -8.53% | -26.76%* | -16.53% |
| Dec | -34.38% | -23.69% | 16.46% | 26.12% | -- | -3.87% |
| Total | -59.94% | -73.52% | -76.44% | -5.56% | -33.19% | -49.73% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical indicators suggest a neutral trend, with no clear uptrend or downtrend
- Recent news headlines are mixed, but generally positive
Primary Risks:
- Regulatory issues, particularly with the FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
- Competition in the ECG device market
Investment Thesis: HSCS has a unique AI-powered ECG algorithm that could potentially disrupt the medical device industry. However, regulatory hurdles and competition pose significant risks.
Recent News Sentiment Impact: The recent news headlines have had a neutral impact on the stock price, with no clear catalysts driving significant moves.
Technical Analysis
Trend Direction: Neutral (Short-term: neutral, Medium-term: neutral, Long-term: bullish)
Support/Resistance Levels:
- SMA 20: $3.04
- SMA 50: $3.00
- Upper Bollinger Band: $3.37
Momentum Signals:
- RSI (14): 39.77 (neutral)
- MACD: -0.08 / Signal: -0.04 / Histogram: -0.04 (bearish)
Volume Analysis: Volume trends suggest institutional interest, with a high volume rate of change.
News & Sentiment Analysis
Recent Headlines Summary:
- HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq (Nasdaq, 2025-10-21) - NEUTRAL
- HeartSciences faces Nasdaq delisting over equity shortfall - Investing.com (Investing.com, 2025-03-21) - NEUTRAL
- HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions - Quiver Quantitative (Quiver Quantitative, 2025-12-15) - POSITIVE
- UK university bets on AI ECG to train future NHS heart specialists - Stock Titan (Stock Titan, 2026-02-05) - NEUTRAL
- HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - Investing News Network (Investing News Network, 2025-06-05) - NEUTRAL
- HeartSciences (HSCS) Stock Forecast and Price Target 2026 - MarketBeat (MarketBeat, 2024-05-16) - NEUTRAL
Sentiment Assessment: Aggregate news sentiment is NEUTRAL.
Catalyst Identification:
- FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm
- Earnings reports and company updates
Market Narrative: The recent news headlines have generally been positive, but the overall trend remains neutral. The market is waiting for more significant catalysts to drive price movements.
Risk & Volatility Assessment
Beta Interpretation: Beta of 0.43 indicates a low risk relative to the broader market.
Volatility Regime: Current volatility levels are lower than historical averages, suggesting a relatively calm market.
Options Market Signals:
- IV rank: Not available
- Put/call ratios: Not available
- Unusual activity: None
Downside Protection: Support levels include SMA 20 and Bollinger Band Lower. Risk management considerations should focus on these levels.
Market Context & Positioning
Sector Performance: HeartSciences operates in the medical device sector, which has been relatively stable recently.
Institutional Activity: Volume trends suggest institutional interest, with a high volume rate of change.
Correlation Analysis: The stock moves relatively independently of the broader market (R-squared interpretation).
Relative Valuation: Position within trading range, with no clear overbought or oversold conditions.
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $3.04
- Upper Bollinger Band: $3.37
Breakout/Breakdown Levels:
- SMA 50: $3.00 (breakout)
- Lower Bollinger Band: $2.70 (breakdown)
Time-Sensitive Catalysts:
- FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm
- Earnings reports and company updates
Risk Management: Stop-loss levels should be set at SMA 20 and Bollinger Band Lower. Position sizing considerations should focus on these levels.
I hope this analysis meets your requirements!
HSCS Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
IV(call wing) − IV(ATM), in vol pointsThe same measure on the upside: how the OTM call is priced against the at-the-money strike.
- Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
- Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $36K | #6077 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
HSCS Institutional Ownership (13F)
Filings for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
HSCS Insider Trading (Form 4)
Latest: 2026-07-09| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-07-09 | Danielle Watson | See Remarks | Grant (A) | +25,000 RSU | — | EDGAR | |
| 2026-06-24 | Andrew Simpson | See Remarks | Award (A) | +425,000 | — | EDGAR |
HSCS Insider Holdings
1 insider · @ $2.19| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Andrew Simpson | See Remarks | 499,382 | $1.09M | $0 | 1 | 2026-06-24 |
HSCS Board & Officers
As of SEC filings through Jul 9, 2026Directors 5
- Andrew Simpson · since Jun 14, 2022
- Brian Szymczak · since Jun 14, 2022
- Bruce Bent · since Jun 14, 2022
- Mark T Hilz · since Jun 14, 2022
- David R. Wells · since Dec 28, 2022
Officers 2
- Andrew Simpson · Chairman of the Board, President and Chief Executive Officer · since Jun 14, 2022
- Danielle Watson · Chief Financial Officer · listed since Jul 2025
Changes in the last 10 years (13)
| Apr 1, 2026 | The company announced the departure of Mark T Hilz as Chief Operating Officer, Secretary and Director in an SEC filing |
| Jul 11, 2025 | Mark T Hilz listed as Chief Operating Officer, Secretary and Director (previously Chief Operating Officer and Secretary) in SEC filings |
| Jul 11, 2025 | Danielle Watson listed as Chief Financial Officer (previously Vice President and Chief Financial Officer) in SEC filings |
| Dec 28, 2022 | David R. Wells became a director |
| Dec 27, 2022 | The company announced the departure of Patrick Kanouff from the board in an SEC filing |
| Jun 14, 2022 | Patrick Kanouff became a director |
| Jun 14, 2022 | Mark T Hilz became a director |
| Jun 14, 2022 | Mark T Hilz became Chief Operating Officer and Secretary |
| Jun 14, 2022 | Danielle Watson became Vice President and Chief Financial Officer |
| Jun 14, 2022 | Bruce Bent became a director |
| Jun 14, 2022 | Brian Szymczak became a director |
| Jun 14, 2022 | Andrew Simpson became a director |
| Jun 14, 2022 | Andrew Simpson became Chairman of the Board, President and Chief Executive Officer |
HSCS Proposed Insider Sales (Form 144)
Latest: 2025-07-29What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-07-29 | HILZ MARK T | Officer, Director | 4,416 | $15.7K | 2025-07-29 | THE CHARLES SCHWAB CORPORATION | 10b5-1 | EDGAR |
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-06 | Other events | EDGAR |
| 2026-10-06 | Regulation FD disclosure | EDGAR |
| 2026-10-02 | Material agreement · New debt obligation | EDGAR |
| 2026-09-17 | Regulation FD disclosure · Other events | EDGAR |
| 2026-09-15 | Earnings results | EDGAR |
| 2026-08-20 | Regulation FD disclosure | EDGAR |
| 2026-08-19 | Regulation FD disclosure | EDGAR |
| 2026-08-18 | Material agreement · Unregistered share sale | EDGAR |
| 2026-08-07 | Listing standards notice | EDGAR |
| 2026-07-29 | Earnings results | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-07-23 | 0001437749-26-024337 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-09-14 | 0001437749-26-030319 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $179,114 | — | 2026-10-31 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
HSCS vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| AXP American Express Company | $211.5B | 17.5 | +8.7% | −16.5% | 66 |
| NU Nu Holdings Ltd. | $58.4B | 18.2 | — | −30.6% | 35 |
| MSTR Strategy Inc Common Stock Class A | $38.2B | — | +0.4% | −45.2% | 100 |
| COIN Coinbase Global, Inc. Class A Common Sto | $29.3B | — | −26.6% | −54.0% | 60 |
| SYF SYNCHRONY FINANCIAL | $21.8B | 7.2 | +0.5% | −18.6% | 72 |
| SOFI SoFi Technologies, Inc. Common Stock | $18.3B | 28.2 | +59.1% | −50.7% | 52 |
| CRCL Circle Internet Group, Inc. | $13.7B | 26.6 | +46.0% | −37.8% | 41 |
| COOP Mr. Cooper Group Inc. Common Stock | $13.5B | — | — | +0.0% | — |
| HSCS HeartSciences Inc. Common Stock | $10M | — | — | −35.4% | — |
| Peer median | $25.6B | 18.2 | +4.6% | −34.2% | 60 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.